Nov 29, 2018
AcelRx Pharmaceuticals to Host Analyst and Investor Day on December 11
Nov 14, 2018
AcelRx Pharmaceuticals to Present at the 17th Annual ASRA Pain Medicine Meeting
Nov 09, 2018
AcelRx Pharmaceuticals Announces Proposed Public Offering of Common Stock
Nov 09, 2018
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Nov 07, 2018
AcelRx Pharmaceuticals to Present at Credit Suisse 27th Annual Healthcare Conference
Nov 02, 2018
AcelRx Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Nov 02, 2018
AcelRx announces FDA approval of DSUVIA(TM)
Oct 19, 2018
AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting
Oct 15, 2018
DSUVIA Efficacy and Safety Data to be Presented at the American Society of Anesthesiologists (ASA) Annual Conference
Oct 12, 2018
FDA Advisory Committee Recommends Approval Of DSUVIA For The Treatment Of Moderate-To-Severe Acute Pain
Oct 12, 2018
AcelRx Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review DSUVIA New Drug Application
Sep 25, 2018
AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October
Sep 11, 2018
AcelRx Announces Date of FDA Advisory Committee Meeting for DSUVIA(TM)
Aug 23, 2018
AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September
Aug 20, 2018
AcelRx Pharmaceuticals to Present at the 2018 Military Health System Research Symposium
Aug 02, 2018
AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial Results
Jul 11, 2018
AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
May 24, 2018
AcelRx announces FDA acceptance of NDA for DSUVIA
May 23, 2018
Three Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry Ventures
May 22, 2018
AcelRx Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference